Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D S Johnson

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Cancer Immunology, Immunotherapy : CII|September 14, 2021
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoidesOleg Kruglov, Lisa D S Johnson, Angela Minic, et al.
Transfusion|November 16, 2023
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapyNirupama Singh, Julie Staves, Jill R Storry, et al.
Plos One|January 5, 2011
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokinesEric Tran, Julie S Nielsen, Darin A Wick, et al.
Human Reproduction (Oxford, England)|January 27, 2010
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocolD S Johnson, G Gemelos, J Baner, et al.
Annals of Internal Medicine|October 15, 1993
Reliability of histologic scoring for lupus nephritis: a community-based evaluationR M Wernick, D L Smith, D C Houghton, et al.
Marine Environmental Research|August 28, 2020
Corrigendum to "Macroinfauna responses and recovery trajectories after an oil spill differ from those following saltmarsh restoration" [Marine Environmental Research 155 (2020) 104881]J W Fleeger, D S Johnson, S Zengel, et al.
Marine Environmental Research|February 20, 2020
Macroinfauna responses and recovery trajectories after an oil spill differ from those following saltmarsh restorationJ W Fleeger, D S Johnson, S Zengel, et al.
NPJ Precision Oncology|July 19, 2023
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibitionHussein Al-Sudani, Ying Ni, Philip Jones, et al.
Journal of Medical Genetics|October 15, 2016
Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the <i>ERF</i> geneM Balasubramanian, H Lord, S Levesque, et al.
Frontiers in Immunology|March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacyMithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|September 14, 2021
The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoidesOleg Kruglov, Lisa D S Johnson, Angela Minic, et al.
Transfusion|November 16, 2023
Transfusion management in the era of magrolimab (Hu5F9-G4), an anti-CD47 monoclonal antibody therapyNirupama Singh, Julie Staves, Jill R Storry, et al.
Plos One|January 5, 2011
Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokinesEric Tran, Julie S Nielsen, Darin A Wick, et al.
Human Reproduction (Oxford, England)|January 27, 2010
Preclinical validation of a microarray method for full molecular karyotyping of blastomeres in a 24-h protocolD S Johnson, G Gemelos, J Baner, et al.
Annals of Internal Medicine|October 15, 1993
Reliability of histologic scoring for lupus nephritis: a community-based evaluationR M Wernick, D L Smith, D C Houghton, et al.
Marine Environmental Research|August 28, 2020
Corrigendum to "Macroinfauna responses and recovery trajectories after an oil spill differ from those following saltmarsh restoration" [Marine Environmental Research 155 (2020) 104881]J W Fleeger, D S Johnson, S Zengel, et al.
Marine Environmental Research|February 20, 2020
Macroinfauna responses and recovery trajectories after an oil spill differ from those following saltmarsh restorationJ W Fleeger, D S Johnson, S Zengel, et al.
NPJ Precision Oncology|July 19, 2023
Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibitionHussein Al-Sudani, Ying Ni, Philip Jones, et al.
Journal of Medical Genetics|October 15, 2016
Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the <i>ERF</i> geneM Balasubramanian, H Lord, S Levesque, et al.
Frontiers in Immunology|March 13, 2025
Maplirpacept: a CD47 decoy receptor with minimal red blood cell binding and robust anti-tumor efficacyMithunah Krishnamoorthy, Ruth Seelige, Christopher R Brown, et al.
Pageof 10